Tekla Capital Management LLC Historic Quarter Change: USA Stocks, Added

Tekla Capital Management LLC historic quarter change: USA Stocks, Added

In share positions in stocks (listed in the US), over 13 quarters from 2013-06-30 to 2016-09-30, Tekla Capital Management LLC opened 83 positions, added to 135, reduced 85 and sold out of 38.

Q3 2016: Stock BIIB; Country of operation United States; Class Common; Shares before 450,533.
Q3 2016: Stock MRK; Country of operation United States; Class Common; Shares before 797,597.
Q3 2016: Stock ABT; Country of operation United States; Class Common; Shares before 953,500.
Q3 2016: Stock JAZZ; Country of operation —; Class Shares; Shares before 156,451.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1300336), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-09); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-12); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-06); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-30); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-05); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-13); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-28); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-30). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-06-30.

Quarter	Stock	Country of operation	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q3 2016	BIIB Biogen Inc.	United States	Common	450,533	482,033	+31,500	$108,948,000	$150,891,000	+$41,943,000	2016-11-14
Q3 2016	MRK Merck & Co., Inc.	United States	Common	797,597	1,246,397	+448,800	$45,950,000	$77,788,000	+$31,838,000	2016-11-14
Q3 2016	ABT Abbott Laboratories	United States	Common	953,500	1,378,600	+425,100	$37,482,000	$58,301,000	+$20,819,000	2016-11-14
Q3 2016	JAZZ Jazz Pharmaceuticals plc		Shares	156,451	331,411	+174,960	$22,108,000	$40,260,000	+$18,152,000	2016-11-14
Q3 2016	LLY Eli Lilly & Company	United States	Common	502,567	713,767	+211,200	$39,577,000	$57,287,000	+$17,710,000	2016-11-14
Q3 2016	CVS CVS Caremark Corporation	United States	Common	223,891	411,891	+188,000	$21,435,000	$36,654,000	+$15,219,000	2016-11-14
Q3 2016	BMRN BioMarin Pharmaceutical Inc.	United States	Common	653,845	710,145	+56,300	$50,869,000	$65,703,000	+$14,834,000	2016-11-14
Q3 2016	CNC Centene Corporation	United States	Common	120,000	256,500	+136,500	$8,564,000	$17,175,000	+$8,611,000	2016-11-14
Q3 2016	HUM Humana, Inc.	United States	Common	129,300	164,800	+35,500	$23,258,000	$29,151,000	+$5,893,000	2016-11-14
Q3 2016	GILD Gilead Sciences, Inc.	United States	Common	2,511,731	2,660,131	+148,400	$209,529,000	$210,470,000	+$941,000	2016-11-14

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet